TechNavio's analysts forecast the Neuromodulation market to grow at a CAGR of 26.3 percent over the period of 2010-2014. One of the key factors contributing to this market growth is that Neuromodulation is considered as standard of care for several diseases. The Neuromodulation market has also been witnessing treatment for chronic headaches. However, restrictions in regulatory approvals could hinder the growth of this market.

Key vendors dominating this market space include Medtronic, Inc., Boston Scientific Corp., St. Jude Medical Inc., DePuy, and Cyberonics Inc.

TechNavio's Global Neuromodulation Market 2010-2014 has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report focuses on the Americas, EMEA, and APAC. It covers the global Neuromodulation market and vendor landscape.

Key questions answered in this report:

What will the market size be in 2014 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary
02. Introduction
03. Market Landscape
04. Vendor Landscape
05. Buying Criteria
06. Market Growth Drivers
07. Drivers and their Impact
08. Market Challenges
09. Market Trends
10. Key Vendor Analysis
- 10.1 Medtronic, Inc.
- 10.2 Boston Scientific Corp.
- 10.3 St. Jude Medical, Inc.
- 10.4 DePuy
- 10.5 Cyberonics, Inc.
11. Other Reports in this Series
List of Exhibits
- Exhibit 1: Global Neuromodulation Market 2010-2014 (US $ Billion)
- Exhibit 2: Geographical Segmentation of Neuromodulation Market - 2010
- Exhibit 3: Market Share of Key Vendors for Neuromodulation Market - 2010

Pharmaceutical Market Research

Global Neuromodulation Market

Global Neuromodulation Market

Key questions answered in this report:

Contents

Related products